Rios et al. demonstrated that CT texture features in lung adenocarcinoma patients could effectively differentiate between EGFR and KRAS mutated gene positivity (AUC = 0.80) (Rios Velazquez et al., 2017). The gene discussed is KRAS; the disease is lung adenocarcinoma.